By Ilan Zipkin
Staff Writer

Successful service providers anticipate customers' needs and make it easier for them to pay to have a job done rather than do the work in-house. CROs have done well by providing clinical development services, but last week's acquisition of combinatorial chemistry and functional genomics capabilities by CRO Pharmaceutical Product Development Inc. (PPDI) may represent a trend to expand the scope of contract services. The next test will be how well such companies integrate drug discovery services into their organizations.